Download | < Back |
14 Nov 2022 | |
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Cyclophosphamide Capsules, 25 mg and 50 mg. Please find enclosed herewith our press release. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |